This inventor holds 1 USPTO granted patent. Top assignee: Aegera Therapeutics, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Kimberly Hewitt: Innovator in Neuroprotective Agents
Introduction
Kimberly Hewitt is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of neuroprotective agents, particularly through her innovative research and development of compounds that address neuronal disorders.
Latest Patents
Hewitt holds a patent for Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides. This invention relates to compounds of Formula (I) and their use as neuroprotective agents in the treatment of neuronal disorders affecting both the central and peripheral nervous systems. Her work in this area has the potential to impact the treatment of various neurological conditions.
Career Highlights
Kimberly Hewitt is associated with Aegera Therapeutics, Inc., where she continues to advance her research in neuroprotection. Her dedication to innovation in this field has established her as a key figure in the development of therapeutic solutions for neuronal disorders.
Collaborations
Hewitt has collaborated with notable colleagues, including James B. Jaquith and Gerald Villeneuve. These partnerships have fostered a collaborative environment that enhances the research and development of neuroprotective agents.
Conclusion
Kimberly Hewitt's contributions to the field of neuroprotective agents exemplify her commitment to innovation and research. Her patent and work at Aegera Therapeutics, Inc. highlight her role as a leading inventor in addressing critical health challenges.